Elevated cleaved caspase-3 is associated with shortened overall survival in several cancer types

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 8, 2014, Pages 5057-5070

  Hu, Qian ^a,b   Peng, Jing ^a,b   Liu, Weiping ^c   He, Xiaoli ^d   Cui, Ling ^e   Chen, Xinlian ^a,b   Yang, Mei ^a,b   Liu, Hongqian ^a,b   Liu, Shanling ^a,b   Wang, He ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c SICHUAN UNIVERSITY   (China)

^d HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^e SICHUAN CANCER HOSPITAL   (China)

Author keywords

Cleaved caspase 3 expression; Multivariate Cox proportional hazards model analysis; Overall survival of cancer patients; Prognosis

Indexed keywords

CASPASE 3; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; APOPTOSIS; COLORECTAL TUMOR; DISEASE COURSE; ENZYMOLOGY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; METABOLISM; MIDDLE AGED; MORTALITY; NEOPLASM; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STOMACH TUMOR; UTERINE CERVIX TUMOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CASPASE 3; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASMS; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84906961597     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Hermens AF, Barendsen GW. Changes of cell proliferation characteristics in a rat rhabdomyosarcoma before and after x-irradiation. EUR J Cancer 1969; 5: 173-189.
2. Stephens TC, Currie GA, Peacock JH. Repopulation of gamma-irradiated Lewis lung carcinoma by malignant cells and host macrophage progenitors. BR J Cancer 1978; 38: 573-582.
3. Tubiana M. Repopulation in human tumors: A biological background for fractionation in radiotherapy. Acta Oncol 1988; 27: 83-8.
4. Trott KR. Cell repopulation and overall treatment time. Int J Radiat Oncol Biol Phys 1990; 19: 1071-5.
5. Huang Q, Li F, Liu X, Li W, Shi W, Liu FF, O'Sullivan B, He Z, Peng Y, Tan AC, Zhou L, Shen J, Han G, Wang XJ, Thorburn J, Thorburn A, Jimeno A, Raben D, Bedford JS, Li CY. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med 2011; 17: 860-866.
6. Donato AL, Huang Q, Liu X, Li F, Zimmerman MA, Li CY. Caspase 3 Promotes Surviving Melanoma Tumor Cell Growth after Cytotoxic Therapy. J Invest Dermatol 2014; 134: 1686-92.
7. Mao P, Smith L, Xie W, Wang M. Dying endothelial cells stimulate proliferation of malignant glioma cells via a caspase 3-mediated pathway. Oncol Lett 2013; 5: 1615-1620.
8. Ryoo HD, Gorenc T, Steller H. Apoptotic cells can induce compensatory cell proliferation through the JNK and the Wingless signaling pathways. Dev Cell 2004; 7: 491-501.
9. Fan Y, Bergmann A. Distinct mechanisms of apoptosis-induced compensatory proliferation in proliferating and differentiating tissues in the Drosophila eye. Dev Cell 2008; 14: 399-410.
10. Chera S, Ghila L, Dobretz K, Wenger Y, Bauer C, Buzgariu W, Martinou JC, Galliot B. Apoptotic cells provide an unexpected source of Wnt3 signaling to drive hydra head regeneration. Dev Cell 2009; 17: 279-89.
11. Li F, Huang Q, Chen J, Peng Y, Roop DR, Bedford JS, Li CY. Apoptotic cells activate the "phoenix rising" pathway to promote wound healing and tissue regeneration. Sci Signal 2010; 3: 110-123.
12. Kuranaga E, Miura M. Nonapoptotic functions of caspases: caspases as regulatory molecules for immunity and cell-fate determination. Trends Cell Biol 2007; 17: 135-144.
13. Lamkanfi M, Festjens N, Declercq W, Vanden Berghe T, Vandenabeele P. Caspases in cell survival, proliferation and differentiation. Cell Death Diffe 2007; 14: 44-55.
14. Huh JR, Guo M, Hay BA. Compensatory proliferation induced by cell death in the Drosophila wing disc requires activity of the apical cell death caspase Dronc in a nonapoptotic role. Curr Biol 2004; 14: 1262-1266.
15. Perez-Garijo A, Martin FA, Morata G. Caspase inhibition during apoptosis causes abnormal signaling and developmental aberrations in Drosophila. Development 2004; 131: 5591-5598.
16. Li F, He Z, Shen J, Huang Q, Li W, Liu X, He Y, Wolf F, Li CY. Apoptotic caspases regulate induction of iPSCs from human fibroblasts. Cell Stem Cell 2010; 7: 508-520.
17. Wang Z, Xu H, Wang S, Chen J. Relationship between new TNM classifi cation and the prognosis and biological behavior of gastric cancer. Zhonghua Wai Ke Za Zhi 2000; 38: 493-505.
18. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
19. Strosberg JR, Nasir A, Hodul P, Kvols L. Biology and treatment of metastatic gastrointestinal neuroendocrine tumors. Gastrointest Cancer Res 2008; 2: 113-25.
20. Trope C. Prognostic factors in ovarian cancer. Cancer Treat Res 1998; 95: 287-352.
21. Rotman M, Sedlis A Piedmonte MR, Bundy B, Lentz SS, Muderspach LI, Zaino RJ. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 2006; 65: 169-176.
22. Kang TB, Ben-Moshe T, Varfolomeev EE, Pewzner-Jung Y, Yogev N, Jurewicz A, Waisman A, Brenner O, Haffner R, Gustafsson E, Ramakrishnan P, Lapidot T, Wallach D. Caspase-8 serves both apoptotic and nonapoptotic roles. J Immunol 2004; 173: 2976-2984.
23. Szymczyk KH, Freeman TA, Adams CS, Srinivas V, Steinbeck MJ. Active caspase-3 is required for osteoclast differentiation. J Cell Physiol 2006; 209: 836-844.
24. Fujita J, Crane AM, Souza MK, Dejosez M, Kyba M, Flavell RA, Thomson JA, Zwaka TP. Caspase activity mediates the differentiation of embryonic stem cells. Cell Stem Cell 2008; 2: 595-601.
25. Kennedy NJ, Kataoka T, Tschopp J, Budd RC. Caspase activation is required for T cell proliferation. J Exp Med 1999; 190: 1891-1896.
26. Liu YR, Sun B, Zhao XL, Gu Q, Liu ZY, Dong XY, Che N, Mo J. Basal caspase-3 activity promotes migration, invasion, and vasculogenic mimicry formation of melanoma cells. Melanoma Res 2013; 23: 243-53.
27. Baskin-Bey ES, Washburn K, Feng S, Oltersdorf T, Shapiro D, Huyghe M, Burgart L, Garrity-Park M, van Vilsteren FG, Oliver LK, Rosen CB, Gores GJ. Clinical trial of the pancaspase inhibitor, IDN-6556, in human liver preservation injury. Am J Transplant 2007; 7: 218-25.
28. Shiffman ML, Pockros P, McHutchison JG, Schiff ER, Morris M, Burgess G. Clinical trial: the effi cacy and safety of oral PF-03491390, a pancaspase inhibitor-a randomized placebo-controlled study in patients with chronic hepatitis C. Aliment Pharmacol Ther 2010; 31: 969-78.
29. Ratziu V, Sheikh MY, Sanyal AJ, Lim JK, Conjeevaram H, Chalasani N, Abdelmalek M, Bakken A, Renou C, Palmer M, Levine RA, Bhandari BR, Cornpropst M, Liang W, King B, Mondou E, Rousseau FS, McHutchison J, Chojkier M. A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis. Hepatology (Baltimore, MD) 2012; 55: 419-28.